A study on gouty arthritis and serum uric acid reducing effect of Homoeopathic medicine Ledum Palustre tincture and 6C under laboratory setting with clinical evaluation of the same.

Ledum Palustre as a modulator of PGE-2 in LPS-stimulated RAW 264.7 cells: A cell line study in gouty arthritis and clinical trial. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109843

Enrollment

Registered

2026-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: LEDUM PALUSTRE: Ledum Palustre Q(Mother Tincture) 10drops in half glass of water twice a day for 5weeks Intervention2: LEDUM PALUSTRE: Ledum Palustre 6C in 40 size globules.3 globules t

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with signs and symptoms of Gouty arthritis 2. Cases with elevated uric acid more than 7 mg/dl .(Gout classification criteria of American College of Rheumatology.) 3. Patients of Both sexes and between 20-70yrs.

Exclusion criteria

Exclusion criteria: 1. Patients with serious associated illnesses and life threatening complications of gout like cardiac complaints, renal failure. 2. Pregnant and lactating women. 3. Immunocompromised individuals.

Design outcomes

Primary

Measure	Time frame
1.To determine the action of Ledum palustre in modulating PGE-2 production in gouty arthritis through cell line study. 2.To determine individual effectiveness of Ledum palustre and Individualised Homoeopathic Medicines in lowering serum uric acid level and reducing severity of symptoms of gout. Timepoint: Serum uric acid will be checked in 3week interval and Symptom severity assessed using Rheumatology and gout activity score in 3months	—

Measure

Time frame

1.To determine the action of Ledum palustre in modulating PGE-2 production in gouty arthritis through cell line study. 2.To determine individual effectiveness of Ledum palustre and Individualised Homoeopathic Medicines in lowering serum uric acid level and reducing severity of symptoms of gout. Timepoint: Serum uric acid will be checked in 3week interval and Symptom severity assessed using Rheumatology and gout activity score in 3months

—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr. ANJALY A L

GOVT HOMOEOPATHIC MEDICAL COLLEGE KOZHIKKODE

drmansoorkr@gmail.com9249337799

Outcome results